Low albumin in critically ill children
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial studies low albumin levels in children who are very sick. It tests if giving albumin can help children with conditions like severe infections, breathing problems, heart issues, and other serious diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Albumin level is less than 3.4 g/dL if your child is 7 months or older
- Albumin level is less than 2.5 g/dL if your child is younger than 7 months
- Your child has a serious illness like severe infection, breathing problem, neurological disease, heart disease, blood disease, or gastrointestinal disease
- Your child does not have immune deficiency, malabsorption, celiac disease, protein-losing enteropathy, nephrotic syndrome, or chronic liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new form of human albumin made from rice for people who need urgent treatment for low albumin levels (hypoalbuminemia) or low blood volume (hypovolemia). It aims to provide a safe and effective alternative to current albumin treatments.
This trial tests if giving human albumin (a protein fluid) can help treat septic shock in surgical intensive care patients. If you have severe infection and very low blood pressure after surgery, this treatment might improve recovery.
This study tests whether giving albumin (a protein in the blood) before heart surgery helps protect the kidneys of young children with low albumin levels. It may help reduce the risk of kidney injury after surgery.
This trial tests whether giving albumin (a blood protein) in a personalized dose works better than a standard fixed dose for people with cirrhosis and sepsis-related acute kidney injury. The goal is to find a safer and more effective way to protect kidney function.
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
This trial tests whether a lower dose of albumin works as well as the standard dose for people with cirrhosis and a type of infection called spontaneous bacterial peritonitis (SBP). It aims to see if the low dose can protect kidney function while reducing side effects and costs.
Hear when a new Hypoalbuminemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.